Protein S is an antithrombotic plasma protein that serves as a cofactor for another plasma protein, activated protein C. Protein S is required for the expression of the anticoagulant effect of activated protein C, which inhibits blood clotting at the levels of factors V and VIII in the blood-clotting cascade. We postulated that patients deficient in protein S would have inadequate regulatory control of the clotting cascade and would be prone to thrombotic disease in a manner similar to that of patients congenitally deficient in protein C. To determine whether protein S deficiency is associated with recurrent thrombosis, we developed a functional assay for the plasma protein. With this assay, the protein S activity of normal persons ranges from 63 to 160 per cent. Using this test, we have now identified six unrelated persons with severe recurrent venous thrombosis who were deficient in protein S, with levels between 15 and 37 per cent while they were not receiving warfarin therapy. Our data suggest that the determination of protein S levels will be useful in the evaluation of patients with recurrent thrombosis.
This article has been cited by other articles:
Dahlback, B.
(2008). Advances in understanding pathogenic mechanisms of thrombophilic disorders. Blood
112: 19-27
[Abstract][Full Text]
D'Angelo, A., Vigano D'Angelo, S.
(2008). Protein S deficiency. haematol
93: 498-501
[Full Text]
Raffini, L.
(2008). Thrombophilia in Children: Who to Test, How, When, and Why?. ASH Education Book
2008: 228-235
[Abstract][Full Text]
de Wolf, C. J.F., Cupers, R. M.J., Bertina, R. M., Vos, H. L.
(2006). Interleukin-6 Induction of Protein S Is Regulated Through Signal Transducer and Activator of Transcription 3. Arterioscler. Thromb. Vasc. Bio.
26: 2168-2174
[Abstract][Full Text]
Cheong, J L, Bucknall, R
(2005). Retinal vein thrombosis associated with a herbal phytoestrogen preparation in a susceptible patient. Postgrad. Med. J.
81: 266-267
[Abstract][Full Text]
Nojima, J., Kuratsune, H., Suehisa, E., Iwatani, Y., Kanakura, Y.
(2005). Acquired Activated Protein C Resistance Associated with IgG Antibodies against {beta}2-Glycoprotein I and Prothrombin as a Strong Risk Factor for Venous Thromboembolism. Clin. Chem.
51: 545-552
[Abstract][Full Text]
Kemmeren, J. M., Algra, A., Meijers, J. C. M., Tans, G., Bouma, B. N., Curvers, J., Rosing, J., Grobbee, D. E.
(2004). Effect of second- and third-generation oral contraceptives on the protein C system in the absence or presence of the factor VLeiden mutation: a randomized trial. Blood
103: 927-933
[Abstract][Full Text]
Koenen, R. R., Tans, G., van Oerle, R., Hamulyak, K., Rosing, J., Hackeng, T. M.
(2003). The APC-independent anticoagulant activity of protein S in plasma is decreased by elevated prothrombin levels due to the prothrombin G20210A mutation. Blood
102: 1686-1692
[Abstract][Full Text]
Anderson, F. A. Jr., Spencer, F. A.
(2003). Risk Factors for Venous Thromboembolism. Circulation
107: I-9-16
[Abstract][Full Text]
Liu, D., Guo, H., Griffin, J. H., Fernandez, J. A., Zlokovic, B. V.
(2003). Protein S Confers Neuronal Protection During Ischemic/Hypoxic Injury in Mice. Circulation
107: 1791-1796
[Abstract][Full Text]
Crowther, M. A., Kelton, J. G.
(2003). Congenital Thrombophilic States Associated with Venous Thrombosis: A Qualitative Overview and Proposed Classification System. ANN INTERN MED
138: 128-134
[Abstract][Full Text]
Edelberg, J. M., Christie, P. D., Rosenberg, R. D.
(2001). Regulation of Vascular Bed-Specific Prothrombotic Potential. Circ. Res.
89: 117-124
[Abstract][Full Text]
YASUI, H., GABAZZA, E. C., TAMAKI, S., KOBAYASHI, T., HATAJI, O., YUDA, H., SHIMIZU, S., SUZUKI, K., ADACHI, Y., TAGUCHI, O.
(2001). Intratracheal Administration of Activated Protein C Inhibits Bleomycin-induced Lung Fibrosis in the Mouse. Am. J. Respir. Crit. Care Med.
163: 1660-1668
[Abstract][Full Text]
Seligsohn, U., Lubetsky, A.
(2001). Genetic Susceptibility to Venous Thrombosis. NEJM
344: 1222-1231
[Full Text]
Noda, K., Wada, H., Yamada, N., Noda, N., Gabazza, E. C., Kumeda, K., Okugawa, T., Yanoh, K., Ito, M., Nakano, T., Shiku, H., Nobori, T., Kato, H., Toyoda, N.
(2000). Changes of Hemostatic Molecular Markers After Gynecological Surgery. CLIN APPL THROMB HEMOST
6: 197-201
[Abstract]
Beatty, S, Eong, K G A.
(2000). Acute occlusion of the retinal arteries: current concepts and recent advances in diagnosis and management. Emerg. Med. J.
17: 324-329
[Abstract][Full Text]
Sanson, B.-J., Simioni, P., Tormene, D., Moia, M., Friederich, P. W., Huisman, M. V., Prandoni, P., Bura, A., Rejto, L., Wells, P., Mannucci, P. M., Girolami, A., Buller, H. R., Prins, M. H.
(1999). The Incidence of Venous Thromboembolism in Asymptomatic Carriers of a Deficiency of Antithrombin, Protein C, or Protein S: A Prospective Cohort Study. Blood
94: 3702-3706
[Abstract][Full Text]
Butenas, S., van't Veer, C., Mann, K. G.
(1999). "Normal" Thrombin Generation. Blood
94: 2169-2178
[Abstract][Full Text]
van de Poel, R. H. L., Meijers, J. C. M., Bouma, B. N.
(1999). Interaction between Protein S and Complement C4b-binding Protein (C4BP). AFFINITY STUDIES USING CHIMERAS CONTAINING C4BP beta -CHAIN SHORT CONSENSUS REPEATS. J. Biol. Chem.
274: 15144-15150
[Abstract][Full Text]
KOBAYASHI, H., GABAZZA, E. C., TAGUCHI, O., WADA, H., TAKEYA, H., NISHIOKA, J., YASUI, H., KOBAYASHI, T., HATAJI, O., SUZUKI, K., ADACHI, Y.
(1998). Protein C Anticoagulant System in Patients with Interstitial Lung Disease. Am. J. Respir. Crit. Care Med.
157: 1850-1854
[Abstract][Full Text]
Long, G. L., Lu, D., Xie, R.-L., Kalafatis, M.
(1998). Human Protein S Cleavage and Inactivation by Coagulation Factor Xa. J. Biol. Chem.
273: 11521-11526
[Abstract][Full Text]
Smiley, S. T., Boyer, S. N., Heeb, M. J., Griffin, J. H., Grusby, M. J.
(1997). Protein S is inducible by interleukin 4 in T cells and inhibits lymphoid cell procoagulant activity. Proc. Natl. Acad. Sci. USA
94: 11484-11489
[Abstract][Full Text]
PIERRE-JACQUES, H., GLUECK, C. J., MONT, M. A., HUNGERFORD, D. S.
(1997). Familial Heterozygous Protein-S Deficiency in a Patient Who Had Multifocal Osteonecrosis. A Case Report. JBJS
79: 1079-84
[Full Text]
van den Belt, A. G. M., Prins, M. H., Huisman, M. V., Hirsh, J.
(1996). Familial Thrombophilia: A Review Analysis. CLIN APPL THROMB HEMOST
2: 227-236
[Abstract]
Hirokawa, S., Mammen, E. F.
(1996). A Functional Protein S and Microlatex Immunoassay for Protein S and C4b-Binding Protein on the Automated Coagulation Laboratory (ACL) 300 Plus. CLIN APPL THROMB HEMOST
2: 268-275
[Abstract]
Kroshus, T. J., Kshettry, V. R., Hertz, M. I., Bolman, R. M. III
(1995). DEEP VENOUS THROMBOSIS AND PULMONARY EMBOLISM AFTER LUNG TRANSPLANTATION. J. Thorac. Cardiovasc. Surg.
110: 540-544
[Abstract][Full Text]
Svensson, P. J., Dahlback, B.
(1994). Resistance to Activated Protein C as a Basis for Venous Thrombosis. NEJM
330: 517-522
[Abstract][Full Text]
McKnight, J. T., Maxwell, A. J., Anderson, R. L.
(1992). Warfarin Necrosis. Arch Fam Med
1: 105-108
[Abstract]
Haley, E. C. Jr, Brashear, H. R., Barth, J. T., Cail, W. S., Kassell, N. F.
(1989). Deep Cerebral Venous Thrombosis: Clinical, Neuroradiological, and Neuropsychological Correlates. Arch Neurol
46: 337-340
[Abstract]
